miR146a and CD4 dysfunction during chronic toxoplasmosis
慢性弓形虫病期间 miR146a 和 CD4 功能障碍
基本信息
- 批准号:9435967
- 负责人:
- 金额:$ 19.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-19 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntigensCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell physiologyCellsChronicCountryDataDevelopmentDiseaseEconomicsEncephalitisExhibitsFoodFunctional disorderFutureGenerationsGoalsHumanImmunityImmunocompetentImmunocompromised HostIndividualInfectionInfection ControlJournalsLaboratoriesLeadLifeLinkMaintenanceMediatingMedicineMetabolicMetabolic PathwayMicroRNAsMusNeuraxisNeurologicPRDM1 geneParasite ControlParasitesPathogenicityPlayPregnancyPublicationsPublishingRegimenRegulationReportingRoleSLEB2 geneSeriesT cell responseT-LymphocyteTNF Receptor-Associated FactorsTRAF6 geneTherapeuticToxoplasmaToxoplasma gondiiToxoplasmosisUnited StatesUp-Regulationbasechronic infectioncongenital infectiondesignexhaustionexperimental studyimmune system functionimmunoregulationimprovedinsightlatent infectionnoveloverexpressionpathogenpreventreactivation from latencytranscription factor
项目摘要
Toxoplasmic gondii, an apicomplexan parasite is a pathogenic protozoan that can infect
the central nervous system. Infection during pregnancy can result in congenital infection
with severe neurological consequences. In immunocompromised individuals reactivation
of latent neurological foci can result in encephalitis. Although CD8+ T cells play an
important effector role in controlling the chronic infection, their maintenance is
dependent on critical help provided by CD4 T cells. In a very recent study we
demonstrated that CD8 T dysfunction leading to reactivation in chronically infected host
is a consequence of CD4 T cell exhaustion. Treatment of chronic host with antigen-
specific non-exhausted CD4 T cells can restore CD8 T cell functionality and prevent
reactivation. Interestingly CD4 exhaustion is linked to up-regulation of transcription factor
BLIMP-1. In this proposal mechanism responsible for CD4 T cell dysfunction/exhaustion
during chronic toxoplasmosis will be interrogated. Preliminary data for the proposal
suggests that increased expression of transcription factor BLIMP-1 on CD4 T cells is due
to up-regulation of miR146a, which likely is a primary cause of their dysfunction. The
proposal has two specific aims. In aim 1 the mechanism responsible for increased
BLIMP-1 expression on CD4 T cells will be evaluated. As preliminary data points at the
role of miR146a, the studies will be performed to determine if in the absence of
miR146a, BLIMP-1 expression can be down-regulated and CD4 T cell exhaustion
prevented. Experiments will be performed to determine if over-expression of miR146a on
non-exhausted CD4 T cells can lead to their dysfunctionality. Preliminary data for the
proposal shows that antigen-specific CD4 T cells from miR146-/- mice express
increased TRAF6 as compared to the cells from wild type animals. In aim 2, studies
related to novel concept that TRAF6 plays an important role in the regulation of BLIMP-1
on CD4 T cells will be performed. We plan to determine if increased BLIMP-1 expression
on CD4 T cells (due to targeting of TRAF6 by miR146a) alters their metabolic pathway.
刚地弓形虫是一种顶复门寄生虫,是一种致病性原生动物,可以感染
中枢神经系统。怀孕期间感染可导致先天性感染
具有严重的神经系统后果。在免疫功能低下的个体中重新激活
潜在的神经病灶可导致脑炎。尽管 CD8+ T 细胞发挥着
在控制慢性感染中发挥重要的效应作用,其维持是
依赖 CD4 T 细胞提供的关键帮助。在最近的一项研究中,我们
证明 CD8 T 功能障碍导致慢性感染宿主重新激活
是 CD4 T 细胞耗竭的结果。用抗原治疗慢性宿主
特定的未耗尽的 CD4 T 细胞可以恢复 CD8 T 细胞的功能并预防
重新激活。有趣的是,CD4 耗竭与转录因子的上调有关
飞艇-1。在该提案中,CD4 T 细胞功能障碍/耗竭的机制
慢性弓形虫病期间将受到询问。提案的初步数据
表明 CD4 T 细胞上转录因子 BLIMP-1 表达增加是由于
miR146a 的上调,这可能是其功能障碍的主要原因。这
提案有两个具体目标。在目标 1 中,负责增加的机制
将评估 CD4 T 细胞上的 BLIMP-1 表达。作为初步数据点
miR146a 的作用,将进行研究以确定是否在缺乏 miR146a 的情况下
miR146a、BLIMP-1 表达可下调且 CD4 T 细胞耗竭
阻止了。将进行实验以确定 miR146a 是否过度表达
未耗尽的 CD4 T 细胞会导致其功能障碍。初步数据
提案表明来自 miR146-/- 小鼠的抗原特异性 CD4 T 细胞表达
与野生型动物的细胞相比,TRAF6 增加。在目标 2 中,研究
与 TRAF6 在 BLIMP-1 调节中发挥重要作用的新概念相关
将在 CD4 T 细胞上进行。我们计划确定 BLIMP-1 表达是否增加
CD4 T 细胞(由于 miR146a 靶向 TRAF6)改变了它们的代谢途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IMTIAZ AHMED KHAN其他文献
Variation of Saccharoid Fraction in Diabetes Mellitus
糖尿病中类糖分数的变化
- DOI:
10.1038/215979a0 - 发表时间:
1967-08-26 - 期刊:
- 影响因子:48.500
- 作者:
IMTIAZ AHMED KHAN;M. ATAUR RAHMAN - 通讯作者:
M. ATAUR RAHMAN
IMTIAZ AHMED KHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IMTIAZ AHMED KHAN', 18)}}的其他基金
CD8+ T Cell exhaustion during Toxoplasmosis
弓形虫病期间 CD8 T 细胞耗竭
- 批准号:
8896135 - 财政年份:2014
- 资助金额:
$ 19.94万 - 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
- 批准号:
8329808 - 财政年份:2012
- 资助金额:
$ 19.94万 - 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
- 批准号:
8700315 - 财政年份:2012
- 资助金额:
$ 19.94万 - 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
- 批准号:
8892976 - 财政年份:2012
- 资助金额:
$ 19.94万 - 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
- 批准号:
8532815 - 财政年份:2012
- 资助金额:
$ 19.94万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 19.94万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别: